Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1099683

Comment on ‘Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from EHRA’


Miličević, Goran
Comment on ‘Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from EHRA’ // Europace, 20 (2018), 11; 1873-1873 doi:10.1093/europace/euy193 (podatak o recenziji nije dostupan, pismo uredniku, ostalo)


CROSBI ID: 1099683 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Comment on ‘Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from EHRA’

Autori
Miličević, Goran

Izvornik
Europace (1099-5129) 20 (2018), 11; 1873-1873

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pismo uredniku, ostalo

Ključne riječi
antiarrhythmic drugs, atrial fibrillation conversion

Sažetak
Criticism of the consensus document from EHRA entitled “Antiarrhythmic drugs–clinical use and clinical decision making” with emphasis on minorization of the significance of the pharmacological conversion of atrial fibrillation.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Klinička bolnica "Sveti Duh",
Medicinski fakultet, Osijek

Profili:

Avatar Url Goran Miličević (autor)

Poveznice na cjeloviti tekst rada:

doi doi.org

Citiraj ovu publikaciju:

Miličević, Goran
Comment on ‘Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from EHRA’ // Europace, 20 (2018), 11; 1873-1873 doi:10.1093/europace/euy193 (podatak o recenziji nije dostupan, pismo uredniku, ostalo)
Miličević, G. (2018) Comment on ‘Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from EHRA’. Europace, 20 (11), 1873-1873 doi:10.1093/europace/euy193.
@article{article, author = {Mili\v{c}evi\'{c}, Goran}, year = {2018}, pages = {1873-1873}, DOI = {10.1093/europace/euy193}, keywords = {antiarrhythmic drugs, atrial fibrillation conversion}, journal = {Europace}, doi = {10.1093/europace/euy193}, volume = {20}, number = {11}, issn = {1099-5129}, title = {Comment on ‘Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from EHRA’}, keyword = {antiarrhythmic drugs, atrial fibrillation conversion} }
@article{article, author = {Mili\v{c}evi\'{c}, Goran}, year = {2018}, pages = {1873-1873}, DOI = {10.1093/europace/euy193}, keywords = {antiarrhythmic drugs, atrial fibrillation conversion}, journal = {Europace}, doi = {10.1093/europace/euy193}, volume = {20}, number = {11}, issn = {1099-5129}, title = {Comment on ‘Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from EHRA’}, keyword = {antiarrhythmic drugs, atrial fibrillation conversion} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font